# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-21-000060
Filing Date
2021-04-23
Accepted
2021-04-23 16:11:40
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | shareholdermeetingnotice.htm | DEFA14A | 13146
2 |  | image_01a.jpg | GRAPHIC | 384238
3 |  | image_02.jpg | GRAPHIC | 12141
4 |  | image_11a.jpg | GRAPHIC | 313282
| Complete submission text file | 0000886163-21-000060.txt |  | 986014

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 21849825
SIC: 2834 Pharmaceutical Preparations